Human Genome Epidemiology Literature Finder
Records 1 - 18 (of 18 Records) |
Query Trace: Pancreatitis and TPMT[original query] |
---|
Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002 Aug 12 (6): 429-36. Schwab Matthias, Schäffeler Elke, Marx Claudia, Fischer Christine, Lang Thomas, Behrens Christoph, Gregor Michael, Eichelbaum Michel, Zanger Ulrich M, Kaskas Bernd |
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 2003 Aug 18 (4): 395-400. Gearry R B, Barclay M L, Burt M J, Collett J A, Chapman B A, Roberts R L, Kennedy M |
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004 Mar 14 (3): 181-7. Marinaki Anthony M, Ansari Azhar, Duley John A, Arenas Monica, Sumi Satoshi, Lewis Cathryn M, Shobowale-Bakre El-Monsor, Escuredo Emilia, Fairbanks Lynette D, Sanderson Jeremy |
Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics 2004 Nov 14 (11): 779-81. Gearry Richard B, Roberts Rebecca L, Barclay Murray L, Kennedy Martin |
Thiopurine methyltransferase (TPMT) heterozygosity and enzyme activity as predictive tests for the development of azathioprine-related adverse events. Journal of the neurological sciences 2005 Apr 231 (1-2): 71-80. Heckmann Jeannine M, Lambson Elisabetta M T, Little Francesca, Owen Elizabeth |
Pharmacogenetics of thiopurine therapy in paediatric IBD patients. Alimentary pharmacology & therapeutics 2006 Apr 23 (8): 1137-41. De Ridder L, Van Dieren J M, Van Deventer H J H, Stokkers P C F, Van der Woude J C J, Van Vuuren A J, Benninga M A, Escher J C, Hommes D |
Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease. World journal of gastroenterology : WJG 2010 Jul 16 (25): 3187-95. Dong Xian-Wen, Zheng Qing, Zhu Ming-Ming, Tong Jing-Lu, Ran Zhi-H |
Risk factors for serious adverse effects of thiopurines in patients with Crohn's disease. Current drug safety 2013 Jul 8 (3): 181-5. Mazor Yoav, Koifman Eduard, Elkin Hela, Chowers Yehuda, Krivoy Norberto, Karban Amir, Efrati Ed |
Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients. World journal of gastroenterology : WJG 2014 Mar 20 (12): 3327-34. Carvalho Ana Teresa P, Esberard Barbara C, Fróes Renata S B, Rapozo Davy C M, Grinman Ana B, Simão Tatiana A, Santos Juliana C V C, Carneiro Antonio José V, Ribeiro-Pinto Luis Felipe, de Souza Heitor S |
Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis. PloS one 2015 10 (3): e0121745. Liu Yue-Ping, Wu Hai-Yan, Yang Xiang, Xu Han-Qing, Li Yong-Chuan, Shi Da-Chuan, Huang Jun-Fu, Huang Qing, Fu Wei-Li |
TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Advances in medical sciences 2015 Dec 61 (1): 135-140. Steponaitiene Ruta, Kupcinskas Juozas, Survilaite Santa, Varkalaite Greta, Jonaitis Laimas, Kiudelis Gediminas, Denapiene Goda, Valantinas Jonas, Skieceviciene Jurgita, Kupcinskas Lim |
Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease. Journal of population therapeutics and clinical pharmacology = Journal de la the?rapeutique des populations et de la pharamcologie clinique 2016 23 (1): e26-36. Al-Judaibi B, Schwarz U I, Huda N, Dresser G K, Gregor J C, Ponich T, Chande N, Mosli M, Kim R |
HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 2017 Dec . Wilson A, Jansen L E, Rose R V, Gregor J C, Ponich T, Chande N, Khanna R, Yan B, Jairath V, Khanna N, Sey M, Beaton M, McIntosh K, Teft W A, Kim R |
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. Medicina (Kaunas, Lithuania) 2019 8 55 (8): . Ribaldone Davide Giuseppe, Adriani Alessandro, Caviglia Gian Paolo, Nicolò Amedeo De, Agnesod Danilo, Simiele Marco, Riganò Danila, Pellicano Rinaldo, Canaparo Roberto, Perri Giovanni Di, D'Avolio Antonio, Luzza Francesco, Saracco Giorgio Maria, Astegiano Mar |
TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India. BMC gastroenterology 2021 Aug 21 (1): 327. Grover Narinder, Bhatia Prateek, Kumar Antriksh, Singh Minu, Lad Deepesh, Mandavdhare Harshal S, Samanta Jayanta, Prasad Kaushal K, Dutta Usha, Sharma Vish |
TPMT and HLA-DQA1-HLA-DRB genetic profiling to guide the use of azathioprine in the treatment of interstitial lung disease: First experience. Pulmonary pharmacology & therapeutics 2021 1 66 101988. Taha Nada, Hosein Karishma, Grant-Orser Amanda, Lin-Shaw Ammy, Mura Mar |
Safety and efficacy of personalized versus standard initial dosing of thiopurines: Systematic review and meta-analysis of randomized trials. Expert opinion on drug safety 2023 7 1-11. Anuraag Jena, Chhagan L Birda, Arup Choudhury, Vishal Shar |
The Role of Pharmacogenetics in the Therapeutic Response to Thiopurines in the Treatment of Inflammatory Bowel Disease: A Systematic Review. Journal of clinical medicine 2023 11 12 (21): . Aline C Ribeiro, Pâmela S A S Gerheim, Julio Maria Fonseca Chebli, Jorge Willian L Nascimento, Priscila de Faria Pin |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: